Transition Clinical Trials

49 recruitingLast updated: June 17, 2026

There are 49 actively recruiting transition clinical trials across 28 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 4, Early Phase 1, Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Basel, Switzerland. Updated daily from ClinicalTrials.gov.


Transition Trials at a Glance

49 actively recruiting trials for transition are listed on ClinicalTrialsFinder across 6 cities in 28 countries. The largest study group is Not Applicable with 22 trials, with the heaviest enrollment activity in Boston, New York, and Basel. Lead sponsors running transition studies include University of Pennsylvania, Australian Cystic Fibrosis Research Trust, and Assistance Publique - Hôpitaux de Paris.

Browse transition trials by phase

Treatments under study

About Transition Clinical Trials

Looking for clinical trials for Transition? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transition trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transition clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 49 trials

Recruiting
Not Applicable

Transition Health and Resilience Through Valued Experiences (THRiVE) Pilot for Newly Separated Veterans

Suicidal IdeationMental HealthAlcohol Misuse+2 more
RTI International40 enrolled1 locationNCT06778278
Recruiting
Phase 3

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Urinary Bladder NeoplasmsNeoplasm MetastasisCarcinoma, Transitional Cell
Eli Lilly and Company450 enrolled284 locationsNCT07218380
Recruiting
Early Phase 1

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

transitional cell carcinomaSoft Tissue SarcomaMelanoma+12 more
University of California, Irvine25 enrolled1 locationNCT07628634
Recruiting
Not Applicable

MICROBIOTA AND BLADDER CANCER

Bladder (Urothelial, Transitional Cell) Cancer
Centre Hospitalier Universitaire de Nice95 enrolled8 locationsNCT07080333
Recruiting

Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT

Bladder (Urothelial, Transitional Cell) CancerBladder Cancer RecurrenceProgression of Bladder Cancer+2 more
Zhiping Wang150 enrolled1 locationNCT07589413
Recruiting

Selecting Hypoxic Tumours for Treatment Modification

Prostate CancerBladder (Urothelial, Transitional Cell) Cancer
University of Manchester30 enrolled1 locationNCT06787053
Recruiting
Not Applicable

Health Care Transition Readiness Short-Form Video Intervention

emotional wellbeingSelf EfficacyHealth Literacy+2 more
Children's Hospital Los Angeles44 enrolled1 locationNCT06842576
Recruiting
Not Applicable

Optimizing Care Transition Process for Older Colorectal Surgery Patients

Colorectal SurgeryOlder Adults (65 Years and Older)Care Transition
Massachusetts General Hospital30 enrolled1 locationNCT06752031
Recruiting
Not Applicable

Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness

Care Transitions
University of Pennsylvania267 enrolled1 locationNCT06203509
Recruiting

Compassionate Care and Organization of Healthcare Services for a Successful Transition in Rheumatology

Chronic Inflammatory Rheumatic Diseases of ChildhoodJuvenile-Onset Chronic Inflammatory Rheumatic DiseasesTransition of Care in Chronic Inflammatory Rheumatic Diseases
Assistance Publique - Hôpitaux de Paris50 enrolled1 locationNCT07469787
Recruiting
Not Applicable

Structured Handoff Using Intelligent Framework for Transitions Trial

transitions of careArtificial Intelligence (AI)Physician Workflow+2 more
University of Pennsylvania90 enrolled1 locationNCT07251907
Recruiting

Association Between Galectin-3 Levels and Outcomes in Patients With Renal Cell Carcinoma, Transitional Cell Carcinoma , Non Small Cell Lung Cancer, and Hepatocellular Carcinoma, Treated With PD-1/PDL-1 Inhibitors

transitional cell carcinomaHepatocellular CarcinomaNon-small Cell Lung Cancer+1 more
Daniel Keizman300 enrolled1 locationNCT07485114
Recruiting
Phase 3

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

Stage IV Ovarian Cancer AJCC v8Stage IIIC Ovarian Cancer AJCC v8Advanced Ovarian Carcinoma+22 more
M.D. Anderson Cancer Center580 enrolled19 locationsNCT04575935
Recruiting

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Urothelial Carcinoma (UC)Bladder (Urothelial, Transitional Cell) CancerLiquid Biopsy
Tianjin Medical University Second Hospital300 enrolled1 locationNCT07441499
Recruiting

Implementation of an adolescent young adult (AYA) paediatric to adult collaborative transition program

Transition of careCancer
Peter MacCallum Cancer Centre75 enrolled1 locationACTRN12626000244303
Recruiting
Not Applicable

Sleep and Light Intervention (SALI) for Menopausal Mood Dysfunction

DepressionMenopausal DepressionDepression During the Menopausal Transition
University of California, San Diego120 enrolled1 locationNCT06678880
Recruiting
Not Applicable

Aim 3: Pilot Study of a Serious Game to Promote Transition Readiness Skills

congenital heart defectTransition to Adult CarePatient-Centered Care+3 more
University of Utah150 enrolled1 locationNCT07042334
Recruiting
Not Applicable

Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Urothelial CarcinomaMuscle-Invasive Bladder CarcinomaBladder Cancer+3 more
Thomas Jefferson University70 enrolled2 locationsNCT07234968
Recruiting
Phase 3

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Transitional Cell Cancer of Renal Pelvis and Ureter
Steba Biotech S.A.100 enrolled18 locationsNCT04620239
Recruiting
Not Applicable

Transition to Hospital Discharge in Insulinized Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM)Continuous Glucose MonitoringCGM+2 more
Instituto de Investigacion Sanitaria La Fe80 enrolled1 locationNCT07061301